GLP-1 medicine for large-blockage stroke after clot removal
Treatments studied
Part of Brain & nervous system, Heart & circulation clinical trials.
This study tests a medicine (a GLP-1 receptor agonist) given along with the standard clot-removal procedure for people who have had a severe stroke from a large blockage. The goal is to see if the medicine helps improve recovery by protecting the brain.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have had a stroke from a blockage in a large brain artery, and you are scheduled for a procedure to remove the clot.
- Your stroke symptoms are still causing at least a moderate level of disability (NIHSS score 6 or more).
- The clot can be removed within 24 hours of your first symptoms, and special brain imaging shows that some brain tissue can still be saved.
- You are 18 years or older.
- You have not already received a clot-dissolving medication for this stroke.
- You were able to do most daily activities on your own before the stroke (no major disability).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medicine (glenzocimab) given along with standard clot-removal procedure for people who had a stroke with a large area of brain damage. The goal is to see if the medicine helps improve recovery.
This trial tests if semaglutide, a diabetes drug, can improve brain recovery after a stroke when given within 24 hours of symptom onset and before a clot-removal procedure. It may help reduce disability and improve neurological outcomes.
This Phase 2 study tests whether a semaglutide injection given under the skin soon after an acute ischemic stroke can improve recovery. It may help reduce disability, especially if treatment starts within about 4.5 hours of symptom onset.
This trial tests whether giving a clot-busting drug (alteplase) directly into the brain artery after a successful clot removal improves recovery in people with severe stroke. It is for patients who have had a thrombectomy and still have a large blocked artery in the front of the brain.
This study tests whether adding a medicine called GM1 to emergency clot-removal surgery helps people recover better from sudden strokes caused by blood clots in major brain arteries. GM1 may protect brain cells from damage during and after the stroke.
This trial tests giving a clot-dissolving medicine (rhPro-UK) through a vein before a procedure to remove a large blood clot in the brain. It is for people who had a stroke 4.5 to 24 hours ago and are already scheduled for clot removal. The goal is to see if the medicine helps improve blood flow and outcomes.
Hear when a new Acute Ischemic Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.